Literature DB >> 17341868

Multicentric Castleman disease with cutaneous manifestations: report of 2 cases and comparison with systemic plasmacytosis.

Yuko Higashi1, Takuro Kanekura, Ryoko Sakamoto, Yuji Mochitomi, Tamotsu Kanzaki.   

Abstract

We report 2 patients with multicentric Castleman disease. Both presented with multiple, indurated, hyperpigmented plaques, generalized lymphadenopathy and polyclonal hypergammaglobulinemia. Biopsy specimens showed infiltration of mature plasma cells and lymphocytes in the dermis and lymph nodes. Skin specimens were negative for human herpesvirus 8, latent nuclear antigen 1 and Epstein-Barr virus by in situ hybridization. PCR disclosed clonal T-cell receptor gene rearrangement in the bone marrow cells of 1 patient. We discuss the possible relationship between multicentric Castleman disease and systemic plasmacytosis as well as plasma cell proliferation. Copyright 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2007        PMID: 17341868     DOI: 10.1159/000098578

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  4 in total

1.  Focal segmental glomerulosclerosis associated with cutaneous and systemic plasmacytosis.

Authors:  Shinsuke Isobe; Naro Ohashi; Naoko Katahashi; Sayaka Ishigaki; Naoko Tsuji; Takayuki Tsuji; Akihiko Kato; Yoshihide Fujigaki; Akira Shimizu; Hideo Yasuda
Journal:  CEN Case Rep       Date:  2017-09-22

2.  Castleman's Disease with Cutaneous Involvement Manifestating as Multiple Violaceous Plaques on Entire Body.

Authors:  Hyeon-Young Park; Je-Jung Lee; Jee-Bum Lee; Seong-Jin Kim; Seung-Chul Lee; Young Ho Won; Sook Jung Yun
Journal:  Ann Dermatol       Date:  2011-10-31       Impact factor: 1.444

3.  Idiopathic multicentric Castleman disease with pulmonary and cutaneous lesions treated with tocilizumab: A case report.

Authors:  Ping-Yang Han; Hui-Hui Chi; Yu-Tong Su
Journal:  World J Clin Cases       Date:  2020-10-26       Impact factor: 1.337

4.  Idiopathic multicentric Castleman disease preceded by cutaneous plasmacytosis successfully treated by tocilizumab.

Authors:  Tetsuro Aita; Sugihiro Hamaguchi; Yoko Shimotani; Yohei Nakamoto
Journal:  BMJ Case Rep       Date:  2020-11-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.